Bimal Pharma Private Limited loan details
Charges taken from banks & financial institutesData last updated:
Amount in (₹)
Bimal Pharma Private Limited has 6 charges registered with the Registrar of Companies: 2 open charges worth Rs 6.41 Cr and 4 satisfied charges worth Rs 2.85 Cr. The lender named on its open charges is Sbi Factors And Commercial Services Ltd.. The most recent charge was created on 14 Jan 2005 for Rs 3.91 Cr and is open.
Charges Breakdown by Lending Institutions
- Others : 3.91 Cr
- Sbi Factors And Commercial Services Ltd. : 2.50 Cr
₹6.41 crore
₹2.85 crore
3
Others
Modification
31 Aug 2021
₹3.91 cr
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 90148523 View Details | The Saraswat Co - Op. Bank Ltd. | ₹ 0.15 | 30 Dec 2003 | - | 22 Apr 2019 | Satisfied |
| 90148167 View Details | The Saraswat Co - Op. Bank Ltd. | ₹ 0.40 | 10 Feb 2003 | 02 Dec 2004 | 22 Apr 2019 | Satisfied |
| 90148163 View Details | The Saraswat Co - Op. Bank Ltd. | ₹ 0.50 | 07 Feb 2003 | - | 22 Apr 2019 | Satisfied |
| 90148141 View Details | The Saraswat Co - Op. Bank Ltd. | ₹ 1.80 | 17 Jan 2003 | - | 22 Apr 2019 | Satisfied |
| 90149037 View Details | Others | ₹ 3.91 | 14 Jan 2005 | 31 Aug 2021 | - | Open |
| 90148862 View Details | Sbi Factors And Commercial Services Ltd. | ₹ 2.50 | 09 Sep 2004 | - | - | Open |
Premium access Charge documents and asset detailsThe filed charge documents and the assets pledged under each charge are in the company report.
Verified entity values are shown only after access is granted. | ||||||
A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.